307 related articles for article (PubMed ID: 11949984)
1. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults.
Fried P; Watkinson B; James D; Gray R
CMAJ; 2002 Apr; 166(7):887-91. PubMed ID: 11949984
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive consequences of marihuana--a comparison with pre-drug performance.
Fried PA; Watkinson B; Gray R
Neurotoxicol Teratol; 2005; 27(2):231-9. PubMed ID: 15734274
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive consequences of cigarette smoking in young adults--a comparison with pre-drug performance.
Fried PA; Watkinson B; Gray R
Neurotoxicol Teratol; 2006; 28(4):517-25. PubMed ID: 16904287
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use and cognitive function: 8-year trajectory in a young adult cohort.
Tait RJ; Mackinnon A; Christensen H
Addiction; 2011 Dec; 106(12):2195-203. PubMed ID: 21749524
[TBL] [Abstract][Full Text] [Related]
5. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
6. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
[TBL] [Abstract][Full Text] [Related]
7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
8. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
Morgan CJ; Muetzelfeldt L; Curran HV
Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
[TBL] [Abstract][Full Text] [Related]
9. Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study.
White J; Mortensen LH; Batty GD
Drug Alcohol Depend; 2012 Sep; 125(1-2):164-8. PubMed ID: 22520690
[TBL] [Abstract][Full Text] [Related]
10. Cognitive function in preschool children after epilepsy surgery: rationale for early intervention.
Freitag H; Tuxhorn I
Epilepsia; 2005 Apr; 46(4):561-7. PubMed ID: 15816951
[TBL] [Abstract][Full Text] [Related]
11. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
12. The relationship between non-acute adolescent cannabis use and cognition.
Harvey MA; Sellman JD; Porter RJ; Frampton CM
Drug Alcohol Rev; 2007 May; 26(3):309-19. PubMed ID: 17454021
[TBL] [Abstract][Full Text] [Related]
13. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
14. Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study.
Meier MH; Caspi A; Danese A; Fisher HL; Houts R; Arseneault L; Moffitt TE
Addiction; 2018 Feb; 113(2):257-265. PubMed ID: 28734078
[TBL] [Abstract][Full Text] [Related]
15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
16. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
Morgan CJ; Muetzelfeldt L; Curran HV
Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
[TBL] [Abstract][Full Text] [Related]
17. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
18. Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age.
Gray KA; Day NL; Leech S; Richardson GA
Neurotoxicol Teratol; 2005; 27(3):439-48. PubMed ID: 15869861
[TBL] [Abstract][Full Text] [Related]
19. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
Milani RM; Parrott AC; Schifano F; Turner JJ
Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
[TBL] [Abstract][Full Text] [Related]
20. Is emotional intelligence impaired in ecstasy-polydrug users?
Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
